Lyla Nsouli Foundation funds Supplement to the DIPG Consortium

We are grateful to the The Lyla Nsouli Foundation for Children’s Brain Cancer Research for the $28,000 supplement to our TheCureStartsNow funded project entitled, "Rapid Preclinical Development of a Targeted Therapy Combination for DIPG".  This supplement allows us to expand our six institution consortium in North America to include 2 other expert laboratories in Europe:
  

• Dannis G. van Vuurden MD, MSc, & Esther Hulleman, VU Cancer Center Amsterdam, and
• Jacques Grill, Institut Gustave-Roussy, Villejuif, France

The ultimate goal is to move the most effective single agent or combination therapy forward to early phase clinical trials in the next 18-24 months. This is the first time that a group of basic and translational scientists and physicians from eight institutions throughout North America and Europe have come together as a consortium to focus on DIPGs and to focus on a bench-to-bedside approach to rationally target therapy for children with DIPGs.

  
For the Open Science Forum week to week update of this project, click here.